Kyle P. D’mello

ORCID: 0009-0003-3214-8309
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • X-ray Diffraction in Crystallography
  • Crystallization and Solubility Studies
  • Immune Cell Function and Interaction
  • Metal-Organic Frameworks: Synthesis and Applications
  • Organoboron and organosilicon chemistry
  • Cancer-related Molecular Pathways
  • Cytokine Signaling Pathways and Interactions
  • Cancer Mechanisms and Therapy
  • Lymphoma Diagnosis and Treatment
  • Immune cells in cancer
  • Cervical Cancer and HPV Research
  • Acute Myeloid Leukemia Research
  • Immunotherapy and Immune Responses
  • Covalent Organic Framework Applications
  • Atherosclerosis and Cardiovascular Diseases
  • Cancer Immunotherapy and Biomarkers
  • Immune Response and Inflammation
  • Boron Compounds in Chemistry
  • Phytochemical compounds biological activities

Des Moines University
2021-2024

The University of Texas Health Science Center at San Antonio
2023

The University of Texas Health Science Center at Houston
2023

University of Iowa
2019

Abstract B←N coordination supports a [2+2] photodimerization in the solid state. The bond is defined by an orthogonal interaction between stilbazole and phenylboronic ester to enable stereocontrolled rapid photoreaction. cyclobutane photoproduct affords novel diboron bis‐tweezer adduct that used separate mixture of benzene thiophene upon crystallization.

10.1002/anie.201812174 article EN publisher-specific-oa Angewandte Chemie International Edition 2019-02-16

Abstract B←N coordination supports a [2+2] photodimerization in the solid state. The bond is defined by an orthogonal interaction between stilbazole and phenylboronic ester to enable stereocontrolled rapid photoreaction. cyclobutane photoproduct affords novel diboron bis‐tweezer adduct that used separate mixture of benzene thiophene upon crystallization.

10.1002/ange.201812174 article EN Angewandte Chemie 2019-02-16

Objective: Ovarian cancer is the deadliest of all gynecologic tumors.Current treatment methods include debulking surgery with chemotherapy, however even treatment, five-year survival rate below 45%.Cancer immunotherapy an innovative option being highly researched.Interleukins (ILs) are signaling molecules used by human immune system to assist in detecting and destroying cells.The ability tumor cells evade a major challenge we face fighting cancer.Ox40L/Ox40 4-1BBL/4-1BB key costimulatory...

10.31083/j.ejgo4302021 article EN European Journal of Gynaecological Oncology 2022-01-01

Lung cancer is the leading cause of mortality due to death. Treatment lung adenocarcinoma (LUAD) still challenging. Cranberries contain many rich bioactive components that may help fight cancer. The action cranberry against some types has been reported, however, its role in only investigated large-cell In this study, we expanded current research on LUAD.A549 LUAD cells were treated with commercial extract (CE). Proliferation A549 was measured a clonogenic survival assay and quick...

10.21873/anticanres.16464 article EN Anticancer Research 2023-06-23
Coming Soon ...